VALPARAISO – IVDiagnostics Inc., a biomedical technology company focused on research on the early detection of cancer, has been selected as a Top 50 Innovator at the New York Venture Summit.

The summit was presented by youngStartup Ventures, which brings cutting edge startups together with venture capitalists and angel investors.

“IVDiagnostics exemplifies a biomedical technology company considered a Top 50 innovator,” said Joe Benjamin, founder and CEO of youngStartup Ventures.

Frank Szczepanski, president and CEO of IVDiagnostics, said, “The company is in a select group of outstanding innovators representing healthcare and biotechnology. IVDiagnostics was formed to develop effective molecular diagnostic tools for oncologists and pathologists. With the ability to monitor and diagnose circulating tumor cells, clinicians will be able to better determine prognosis of blood-borne diseases and prescribe personalized medicine.”